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Imaging mass spectrometry allows for the direct investigation of tissue samples to identify
specific biological compounds and determine their spatial distributions. Desorption electros-
pray ionization (DESI) mass spectrometry has been used for the imaging and analysis of rat
spinal cord cross sections. Glycerophospholipids and sphingolipids, as well as fatty acids,
were detected in both the negative and positive ion modes and identified through tandem
mass spectrometry (MS/MS) product ion scans using collision-induced dissociation and
accurate mass measurements. Differences in the relative abundances of lipids and free fatty
acids were present between white and gray matter areas in both the negative and positive ion
modes. DESI-MS images of the corresponding ions allow the determination of their spatial
distributions within a cross section of the rat spinal cord, by scanning the DESI probe across
the entire sample surface. Glycerophospholipids and sphingolipids were mostly detected in
the white matter, while the free fatty acids were present in the gray matter. These results show
parallels with reported distributions of lipids in studies of rat brain. This suggests that the
spatial intensity distribution reflects relative concentration differences of the lipid and fatty
acid compounds in the spinal cord tissue. The “butterfly” shape of the gray matter in the spinal
cord cross section was resolved in the corresponding ion images, indicating that a lateral
resolution of better than 200 m was achieved. The selected ion images of lipids are directly
correlated with anatomic features on the spinal cord corresponding to the white and the gray
matter. (J Am Soc Mass Spectrom 2010, 21, 1177–1189) © 2010 Published by Elsevier Inc. on
behalf of American Society for Mass SpectrometryIncreased recognition of the important functions oflipids in biological organisms [1, 2], coupled withthe availability of new and more powerful analytical
methods of characterizing compounds of this diverse
class [3, 4], has propelled the rapid recent growth of the
field of lipidomics [5–7]. The diverse functions of lipids
include maintaining an electrochemical gradient, sub-
cellular partitioning, cell signaling, energy storage, and
membrane anchoring [2]. The most widely recognized
role of lipids is to form the lipid bilayer of cellular and
organelle membranes [8]. It has been reported that
alterations in the glycerophospholipid composition of
tissues occur in several diseases, including cancer [9]
and Alzheimer’s disease [10]. Particular glycerophos-
pholipids and their enzymatic products have been
identified in malignant transformations in tissue [11,
12]. In other cases, the expression of phosphatidylserine
in the outer leaflet of the membrane has been found to
play a role in the recognition of altered cells, such as
cancer cells, by macrophages [13, 14]. Lipids also play a
role in atherosclerosis [15–17]. Indeed, the propensity of
atherosclerotic plaques to rupture may be influenced by
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doi:10.1016/j.jasms.2010.03.028their lipid content and the distributions of these lipids
within the plaque [18]. Differences in the content of
specific lipids including cholesterol in plaque have been
detected among the different types of plaque [19].
Lipids are the most common biomolecules found in
the spinal cord and make up 50% of its dry weight [20,
21]. The morphology of the spinal cord consists of white
matter, the peripheral region containing sensor and
myelinated axons, which surrounds the gray matter,
composed primarily of neuronal cell bodies [21]. The
spinal cord transmits neural signal between the periph-
eral nervous system and the brain and thus serves for
the study of neuronal transmission, including neurolog-
ical disability [22, 23]. Understanding the nature of such
complex biological processes in tissue requires identi-
fying the specific compounds involved and determin-
ing where they are located in space and how they
change in time. Information on some of these matters is
available from studies on neurotransmitters using in
situ microelectrodes [24, 25], ultrafiltration followed by
chromatography/mass spectrometry [26, 27], and other
methods [28–30].
Imaging mass spectrometry (MS) has become an
increasingly important tool for the study of complex
biological systems, allowing one to record spatial and
chemical information simultaneously for multiple ana-
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1178 GIROD ET AL. J Am Soc Mass Spectrom 2010, 21, 1177–1189lytes over the sample area. Each pixel on the scanned
surface yields a mass spectrum, which can then be
compiled to create an image showing the spatial distri-
bution of particular compounds [31, 32]. Such an image
can provide chemical correlations with biological func-
tion or morphology. The limitations of the approach are
that it is highly invasive so time course information is
difficult to obtain. Matrix-assisted laser desorption/
ionization (MALDI) and secondary ion mass spectrom-
Figure 1. Negative ion DESI mass spectrum re
using MeOH-water 70:30 (% vol/vol) as the solv
of the mass range from m/z 650 to 1000, includin
lipids. The most intense peaks for each class of lipidetry (SIMS) imaging have been used extensively.
MALDI imaging is applicable to large molecules such
as proteins [33–40] and peptides and can provide a
spatial resolution of 100 m [39]; experiments are
typically conducted under high vacuum and after ap-
plication of an organic matrix to the sample to assist in
ionization. Although the method has been primarily
applied to proteins, MALDI has seen increasingly wide
use in the investigation of distributions of lipids [41–
d on a 15 m thick rat spinal cord cross-section
ray. (a) Full mass spectrum. (b) Expanded view
molecular ion, [M  H], signals from severalcorde
ent sp
g thes are annotated.
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a variety of other applications [55, 56]. Imaging using
SIMS potentially provides the advantage of very high
spatial resolution of 100 nm and can be performed
without additional sample preparation [51, 57–61].
However, SIMS imaging cannot be conducted under
ambient conditions and is a harsher ionization tech-
nique that tends to produce more dissociation than
MALDI. Desorption electrospray ionization (DESI)
mass spectrometry [62] was introduced as a method for
the direct analysis of biological samples, including
tissue sections. DESI offers the advantage of little or no
sample preparation as it does not require the addition
of matrix compounds and is conducted at atmospheric
pressure under ambient conditions [62]. Its disadvan-Schemetages include a poorer spatial resolution than MALDI. It
is one of a group of ambient ionization methods [63–65]
amongst which the laser-based method of laser ablation
electrospray ionization (LAESI) [66, 67] has given par-
ticularly useful images of biological systems, including
in vivo systems. In DESI, a pneumatically-assisted elec-
trospray produces charged droplets, which are directed
at the surface of the sample, creating a thin liquid film
which dissolves the analytes [68, 69]. The impact of
subsequent primary droplets releases secondary micro-
droplets containing analytes [68, 69]. This so-called
‘droplet pick-up’ process is followed by the standard
electrospray evaporation mechanisms which produce
dry ions of the analytes [70, 71]. DESI has been used to
construct chemical images of tissue sections [72–86] and1
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DESI is typically 200 m [74] although significantly
higher resolution has been reported [75].
This work presents a study of rat spinal cord tissue
sections examined by DESI imaging mass spectrometry.
Tissues sections were analyzed in both the negative and
positive ion modes and tandem mass spectrometry
(MS/MS) and exact mass measurements were used to
identify the compounds detected. The major challenge
to this application of DESI imaging mass spectrometry
was the 4 mm size of the rat spinal cord section, which
requires a high spatial resolution as reported in previ-
ous SIMS [89] and MALDI [90] imaging for spinal cord
samples. The present aim was to establish if the distri-
Figure 2. DESI-MS/MS spectra of (a) [plasm
(c) [PE(18:0/22:4)  H], (d) [PG(18:1/20:5)  H
H] ions (collision energy: 25 eV, laboratory fram
fragment ions produced consecutively after eliminatibution of lipids within rat spinal cord tissue sections
could be determined and whether DESI lipid imaging
mass spectrometry has the potential to serve as a tool
for future detection of analyte changes in injured spinal
cord samples.
Experimental
Chemicals and Biological Samples
Methanol (MeOH) was purchased from Sigma-Aldrich
(St. Louis, MO, USA), and water (18.2 M-cm) was
from a PureLab Ultra system by Elga LabWater (High
Wycombe, UK). Adult male Long-Evans rats (Hilltop
18:0/20:4)  H], (b) [PS(18:0/18:1)  H],
) [PI(18:0/20:4)  H], and (f) [ST(18:1/24:1) 
umbers in brackets correspond to the m/z of the-PE(
], (e
e). Non of a portion of the head group.
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350 g were used.
Tissue Preparation
All protocols for this experiment were approved by the
Purdue Animal Care and Use Committee. All rats were
anesthetized deeply with a mixture of 90 mg/kg ket-
amine and 5 mg/kg xylazine and sacrificed by transcar-
dial perfusion with cold PBS followed by 4% parafor-
maldehyde. The seventh thoracic (T7) spine was
removed by laminectomy. The spinal tissue about 1 cm
long was cryostat-sectioned at 15 m thickness and
serially thaw-mounted on glass slides. The slices were
dried in the air under room temperature for 2 h,
rehydrated in PBS solution for 15 min, and washed once
with PBS. Before imaging experiments, samples were
dried under vacuum 15 min.
Mass Spectrometry
DESI imaging analysis were performed with a commer-
cial Thermo Scientific LTQ (San Jose, CA, USA) linear
ion trap mass spectrometer equipped with a custom-
built, automated DESI source operated in both the
negative and positive ion modes. The home-built DESI
ion source is similar to the OmniSpray source from
Prosolia Inc. (Indianapolis, IN, USA), configured as
described previously [91]. A sprayer-to-surface distance
of 2 mm, a sprayer-to-inlet distance of 2.5 mm, an
incident angle to the horizontal of 52° and a collection
angle of 10° were used. The spray voltage was set at
5000 V and the capillary voltage at 5 V. Nitrogen gas
was used as the nebulizing gas (140 psi). MeOH-water
70:30 (% vol/vol) was sprayed at a constant flow rate of
1.5 L/min. For the MS/MS experiments, a series of
line scans across the tissue sample was performed
during a period of about 1 min. An isolation window of
1.5 mass/charge units, a normalized collision energy of
20%–40% (manufacturer’s units) and a Mathieu param-
eter qz value of 0.25 during collisional activation were
used. Exact mass measurements were performed using
a commercial Thermo Scientific LTQ-Orbitrap XL mass
spectrometer (Bremen, Germany), with the resolution
set to 100,000 to confirm molecular formulae. Mass
standards were added into the DESI spray at a concen-
tration of 10 ppm. The [M  H] ion of taurocholate
and C15H15O6N3P3F20(C2F4)2 Ultramark 1621 peak, with
theoretical exact masses of 514.2839 and 1005.9727,
respectively, were used as standards in the negative ion
mode. The [M  H] ion of reserpine and the [M 
Na] ion of cyclosporine A, theoretical exact masses of
609.2812 and 1224.3311, respectively, were used in the
positive ion mode [92].
In the imaging experiments, the tissue was scanned
using a 2D moving stage (Newport, Richmond, CA,
USA) in horizontal rows separated by a 150 m vertical
step until the entire tissue sample was analyzed [81].
The lines were scanned at a constant velocity of 132m/s, while collecting one mass spectrum every 1.16 s
over the range m/z 150–1000. The ion injection time was
set to 500 ms and 5 microscans were averaged. Under
these conditions, a lateral spatial resolution of 200 m
can be achieved in DESI MS imaging [74].
Xcalibur 2.0 software (Thermo Scientific LTQ, San
Jose, CA, USA) was used for instrument control, data
acquisition and data processing. Lab-written software
was used to convert the Xcalibur mass spectra files
(.raw) into a format compatible with BioMap. BioMap
(freeware, http://www.maldi-msi.org/) was used to
process the mass spectral data to generate two-
dimensional ion images.
Table 1. Molecular species detected from rat spinal cord tissue
in negative ion mode
m/z Molecular speciesa
Relative intensity in
spinal cord tissue
section (%)b
255.4 Palmitic acid (16:0) 18.2
281.4 Oleic acid (18:1) 20.3
283.4 Stearic acid (18:0) 16.8
303.4 Arachidonic acid (20:4) 23.7
327.4 Docosahexaenoic acid (22:6) 13.1
563.5 Dimer of oleic acid (18:1) 5.6
607.5 Dimer of arachidonic acid (20:4) 4.4
700.6 plasm-PE (34:1) 13.2
701.6 SM (34:1) 7.8
726.6 plasm-PE (36:2) 11.9
750.6 plasm-PE (38:4) 15.3
757.6 SM (38:1) 8.7
768.3 PE (38:3) 11.5
774.6 plasm-PE (40:6) 12.6
786.5 PC (36:1) 6.4
788.5 PS (36:1) 22.5
794.4 PE (40:4) 24.1
796.5 PE (40:3) 8.6
806.7 ST (18:0) 46.3
810.5 PS (38:4) 13.8
821.7 PG (40:6) 26.4
834.6 PS (40:6) 15.2
857.6 PI (36:4) 16.3
862.8 ST (22:0) 30.7
878.8 ST (h22:0) 22.5
885.6 PI (38:4) 38.4
888.8 ST (24:1) 100
890.9 ST (24:0) 73.2
904.8 ST (h24:1) 38.6
906.8 ST (h24:0) 45.7
916.7 ST (26:1) 8.5
918.8 ST (26:0) 9.5
932.7 ST (h26:1) 3.5
934.7 ST (h26:0) 4.1
All species are detected as deprotonated forms.
a(X:Y) represents the different number of carbon atoms and different
number of double bonds in the fatty acid chains. The notation (hX:Y)
denotes a hydroxylated sulfatide species.
bRelative intensities were calculated with respect to the base peak
intensity.
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Identification of Compounds
Before the imaging experiments, the DESI experimental
conditions were optimized to maximize the signal in-
tensity obtained from the thin tissue sections in both the
negative and positive ion modes. A series of line scans
across the tissue sample was performed and the result-
ing mass spectra were examined.
The negative ion DESI mass spectrum from a rat
spinal cord section is shown in Figure 1. In the low
mass/charge region (m/z 200–400), ions corresponding
to deprotonated free fatty acids are detected. These fatty
acids can only be tentatively identified, since the possi-
bility of isomers must be allowed. Based on the mass of
the molecular anion, m/z 255 is a palmitic acid (16:0),
m/z 281 is an oleic acid (18:1), m/z 283 is a stearic acid
(18:0), m/z 303 is an arachidonic acid probably (20:4),
and m/z 327 is a docosahexaenoic acid (22:6). The region
from m/z 500 to m/z 650 includes dimers of the free fatty
acids. In the high m/z region (m/z  600), ions corre-
sponding to the deprotonated forms of various lipids
are detected. Figure 1b shows an expanded view of the
DESI mass spectrum in the m/z range 650–1000. The
lipid species detected from the rat spinal cord section
mainly consist of sulfatides (ST), glycerophospho-
serines (PS), glycerophosphoinositiols (PI), glycero-
phosphoethanolamines (PE) and plasmalogens (plasm-
PE), glycerophosphoglycerols (PG) and, with a lower
intensity, glycerophosphocholines (PC) and sphingo-
myelin (SM), as denoted in Figure 1b. Only the most
intense peaks for each class of lipids have been anno-
tated for better clarity. With a quaternary amine in the
head group (Scheme 1), PC and SM ionize poorly in the
negative ion mode (and well in the positive mode),
Figure 3. Expanded view of the mass range fro
recorded on a 15 m thick rat spinal cord cross
solvent spray. The most intense peaks for each classwhile the polar PS, PG, PI, PE, and ST lipids ionize
better in the negative ion mode [93, 94]. Confirmation of
the lipid assignments was achieved by tandem mass
spectrometry (MS/MS) experiments (Figure 2), spectral
comparisons with authentic lipid standards and com-
parisons to existing electrospray (ESI) mass spectra [94].
The molecular ion detected at m/z 750.6 has been
identified as [plasm-PE(18:0/20:4)  H] based on its
MS/MS behavior (Figure 2a). Loss of the ethanolamine
portion of the head group (43 Da) from the precursor
ion produces [M  H  C2H3NH2]
, m/z 707.5. The
fragment ion detected at m/z 464.2, corresponding to
[M  H  C18H29CHCO]
, would arise from the loss of
the fatty acid chain at the sn-2 position as an alkyl
ketene [95]. This reaction could also occur after the prior
elimination of the ethanolamine portion of the head
group (43 Da), yielding the ion detected at m/z 421.1,
denoted [M  H  C18H29CHCO  C2H3NH2]
. The
ion denoted [M  H  C19H31COOH]
, detected at m/z
421.1, could be the result of loss of the fatty acid chain
at the sn-2 position while the carboxylate anion
[C19H31COO]
 from the C20:4 fatty acid chain is de-
tected at m/z 303.1 [95]. However, ions due to different
compounds may still overlap. To minimize this possi-
bility and separate likely isobaric lipids, high-resolution
MS was performed by analyzing the tissues using DESI
on the Orbitrap (see Figure S1 in the Supplementary
Material). The results show that peak at m/z 750.5411
can be accurately assigned as having the exact mass of
[plasm-PE(18:0/20:4)  H] with an error of 4.4 ppm.
The ion detected at m/z 788.5 in the MS spectrum
(Figure 1) has been identified as [PS(18:0/18:1)  H]
(m/z 788.5463, error: 2.0 ppm on the DESI-Orbitrap).
The MS/MS spectrum (Figure 2b) shows a predominant
loss of 87 Da from the precursor ion corresponding to
650 to 1000 of the positive DESI mass spectrum
on using MeOH-water 70:30 (% vol/vol) as them m/z
-sectiof lipids are annotated.
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would give rise to the [M  H  C3H5NO2]
 fragment
ion detected atm/z 701.5. The consecutive elimination as
an alkyl ketene from the fatty acid chains at the sn-1 and
sn-2 position from the [MHC3H5NO2]
 fragment ion
are observed, as well as the consecutive elimination of
the C18:0 and C18:1 fatty acid chains from the [M  H
 C3H5NO2]
 fragment ion [93, 94]. Fatty carboxylic
acid anions ([C17H35COO]
 and [C17H33COO]
) are
detected at m/z 283.1 and 281.1. Returning to the mass
spectrum, the ion detected at m/z 794.4 has been iden-
tified as [PE(18:0/22:4)  H] on the basis of its
accurate mass (m/z 794.5685, error: 2.6 ppm on the
DESI-Orbitrap) and its MS/MS behavior (Figure 2c) [96,
97]. As the plasmalogen deprotonated species previ-
ously described, the precursor ion is expected to elim-
Figure 4. DESI-MS/MS spectra of (a) [PC(16:0
(collision energy: 25 eV, laboratory frame).inate the ethanolamine portion of the head group (43
Da), yielding the ion detected at m/z 751.4, noted [M 
H  C2H3NH2]
. Loss of fatty acid chain either at the
sn-1 or sn-2 position from the precursor ion are also
observed and corresponding fatty carboxylic acid an-
ions are detected at m/z 283.0 and m/z 331.0, respec-
tively. The elimination as an alkyl ketene from one of
the fatty acid chains at the sn-1 and sn-2 positions in the
precursor ion or from the [M  H  C2H3NH2]

fragment ion complete this accounting of the observed
fragmentation pathways. The MS/MS spectrum of the
ion detected at m/z 821.7 (m/z 821.5368, error: 3.5 ppm
on the DESI-Orbitrap) allows the anion to be identified
as [PG(18:1/20:5)  H] (Figure 2d) [98–100]. The
fragment ion ([M  H  C3H6O2]
) detected at m/z
747.7 would arise from the elimination of the glycerol
)  Na], and (b) [SM(18:1/24:0)  Na] ions/18:1
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the elimination of the fatty acid chain either at the sn-1
or sn-2 position can occur from both the precursor ion
and the [M  H  C3H6O2]
 ion. Fatty carboxylic acid
ions ([C17H33COO]
 and [C19H21COO]
) are detected at
m/z 281.0 and m/z 301.1. Loss of the C18:1 or the C20:5
chain as a ketene neutral also occurs from the precursor
ion and from the [MH C3H6O2]
 fragment ion. The
MS/MS spectrum of the ion detected at m/z 885.6 (m/z
885.5514, error: 1.7 ppm on the DESI-Orbitrap) allows
one to identify the anion as [PI(18:0/20:4)H] (Figure
2e). The fragment ion ([M  H  C8H10O5]
) detected
at m/z 723.5 would arise from the elimination of the
inositol head group (162 Da) from the precursor ion.
Thus, this ion fragments to give three major series of
product ions that are formed by neutral loss of free fatty
acid, neutral loss of ketene and by formation of fatty
carboxylate anions [101]. Sulfatides differ from the
lipids discussed thus far in that they do not contain a
glycerol-phosphate backbone but instead possess a
sphingosine base (Scheme 1). Sulfatide fragmentation
described in the literature shows several complex pro-
cesses [93, 102, 103]. The collision induced dissociation
of the [ST(18:1/24:1)  H] ion detected at m/z 888.8
(m/z 888.6255, error: 1.5 ppm on the DESI-Orbitrap),
gives rise to a peak at m/z 522.5 ([M  H 
C22H43CHCO  H2O]
), which corresponds to the loss
of water and the amide linked ketene by cleavage of the
amine bond (Figure 2f). Loss of water molecule from the
precursor ion is indicated by the product ion at m/z
870.8 ([M  H  H2O]
). The fragment of m/z 390.5
([C26H48ON]
) would arise from the cleavage of the
C2–C3 bond of the sphingosine backbone along with
loss of the head group via cleavage of the C1–O bond.
The fragment ion detected at m/z 650.6 ([M  H 
C16H29OH]
) appears to arise from loss of the long-
chain base after the second carbon. Loss of the chain as
a ketene neutral at the sn-2 position from the precursor
ion would give rise to the [M  H  C22H43CHCO]

ion, detected at m/z 540.5. Finally, the ion detected at
m/z 259.3 corresponds to the polar head group anion
[C6H11O9S]
. All of the other peaks in the lipid profile
of the spinal cord can likewise be identified based on
their CID spectra. A summary of the peak assignments
and the relative abundances in the whole spinal cord for
negative ion [M  H] ions is given in Table 1. These
data are consistent with previously reported MS anal-
ysis of rat brain sections [45, 80, 89]. Although the
sulfatide lipids are not the most abundant in rat spinal
cord [21], they correspond to the main detected ions in
the negative ion mass spectrum, their more efficient
ionization being due to the high acidity of the sulfonic
group.
In the positive ion mode, ions are detected in the
high m/z region with a lower signal/noise ratio than in
negative mode, as shown in the expanded view of the
DESI mass spectrum in the m/z range 650–1000 (Figure
3). The major biomolecules detected are glycerophos-
phocholines (PC), sphingomyelin (SM), and glycero-phosphoethanolamines (PE), and plasmalogens (plasm-
PE) as protonated [M  H] or sodiated [M  Na]
adducts. Only the most intense peaks for each class of
lipids have been annotated for clarity, but the mass
spectrum in Figure 3 is dominated by PC species.
MS/MS experiments were also performed on the tissue
samples and compared to published fragmentation [93,
94, 104] to identify the lipids detected in the full scan
mass spectra, as well as accurate mass measurements
on the DESI-Orbitrap (see Figure S1 in the Supplemen-
tary Material). Indeed, based on its fragmentation be-
havior, the ion detected at m/z 782.8 in the MS spectrum
(m/z 782.5704, error: 4.5 ppm on the DESI-Orbitrap)
has been identified as [PC(16:0/18:1)  Na]. Predom-
inant loss of 59 Da, representing the (CH3)3N group
[105–110], from the precursor ion is indicated by a
product ion at m/z 723.5 ([M  (CH3)3N  Na]
) as
shown in the MS/MS spectrum (Figure 4a). Loss of the
polar head group is also observed and gives rise to
the sodiated adduct detected at m/z 599.5 ([M 
C5H14O4NP  Na]
). Additionally, the fragment cation
detected at m/z 577.4 ([M  C5H13O4NPNa]
) would be
expected to arise from the loss of the sodiated-complex
of the polar head group (205 Da) from the precursor ion
[107, 108]. Two ions are detected at m/z 500.4 and 526.4
with low abundance and correspond to the loss of one
of the two fatty acids (C16:0 and C18:1, respectively)
from the precursor ion. Similarly, the peaks at m/z 837.8
(m/z 837.6767, error:6.3 ppm using the DESI-Orbitrap)
has been identified as [SM(18:1/24:0)  Na]. The
MS/MS spectrum of this ion (Figure 4b) shows a
Table 2. Molecular species detected from rat spinal cord tissue
in positive ion mode
m/z
Molecular
speciesa
Relative intensity in spinal
cord tissue section (%)b
736.6 PE (36:6)d 63.4
751.6 PC (32:3)c 18.6
756.6 PC (32:0)c 28.4
768.8 PE (38:4)d 32.9
782.8 PC (34:1)c 100
794.7 PE (38:2)c 14.2
796.7 PE (38:1)c 16.9
810.8 PC (36:1)c 71.6
822.6 PE (40:2)c 11.5
832.8 PC (38:4)c 35.4
836.8 PC (38:2)c 15.2
837.8 SM (42:1)c 18.1
846.7 PC (40:0)d 9.7
850.8 PC (38:3)e 22.4
865.6 SM (44:1)c 7.5
868.7 PC (40:1)c 8.3
894.7 PC (42:1)c 4.1
910.7 PE (46:0)c 5.6
a(X:Y) represents the different number of carbon atoms and different
number of double bonds in the fatty acid chains.
bRelative intensities were calculated with respect to the base peak
intensity.
cSpecies detected as sodiated adducts.
dSpecies detected as protonated adducts.
eSpecies detected as potassiated adducts.
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of the (CH3)3N group from the precursor ion [111],
yielding the fragment ion detected at m/z 778.8, denoted
[M  (CH3)3N  Na]
. The most abundant fragment
ion detected at m/z 654.6 ([M  C5H14O4NP  Na]
)
corresponds to the of the polar head group (183 Da)
from the precursor ion [111]. In addition, very low
abundance peaks at m/z 596.5 and m/z 489.4 are de-
tected, corresponding, respectively, to the elimination
of the long-chain base after the second carbon ([M 
C16H19O4H  Na]
) and the fatty acid chain as a ketene
neutral ([M  C22H43CHCO  Na]
) from the precur-
Figure 5. Selected molecular ion [M  H] ima
a 3.8  3.5 mm area of rat spinal cord cross s
plasm-PE(38:4), (b) PS(36:1), (c) PE(40:4), (d) PG(
(i) (22:6). (j) Optical image of the rat spinal cord crossor ion. All of the other peaks in the lipid profile of the
spinal cord can likewise be identified based on their
CID spectra. A summary of the peak assignments and
the relative abundances in the whole spinal cord pro-
tonated [M  H] and sodiated [M  Na] adducts is
given in Table 2.
Reported MS studies of rat brain tissues have also
yielded strong mass peaks associated with PC in posi-
tive ion mode [43, 44, 93, 112]. Although glycerophos-
phocholines (PC) and glycerophosphoethanolamines
(PE) have similar concentrations in rat spinal cords [21],
the relative abundances of the PE species are weak
f specific lipids and fatty acids from analysis of
n in the negative ion mode. Ion images of (a)
(e) PI(38:4), (f) ST(24:1), (g) (18:1), (h) (20:4), andges o
ectio
40:6),s-section.
1186 GIROD ET AL. J Am Soc Mass Spectrom 2010, 21, 1177–1189compared to PC in the positive mass spectra. Indeed,
PC are characterized by the presence of a quaternary
ammonium group whose positive charge is neutralized
by the negative charge of the phosphate group (Scheme
1). Thus, PC readily forms an abundant sodiated species
when Na ions are present in the sample because the
phosphate anion can be easily sodiated during the DESI
process in the positive ion mode. Furthermore, MS
studies of standard phospholipid mixtures have shown
that in positive ion mode PC and SM (both contain a
quaternary ammonium group) suppress the detection
of other phospholipid classes [113, 114].
Tissue Imaging
Tissue imaging experiments allow correlation of chem-
ical information with morphological features of the
sample. Rat spinal cord cross sections were imaged
using DESI-MS in both the negative and the positive ion
modes. Each image is a representation of the distribu-
tion of ions of one particular m/z value and hence a
representation of the distribution of the corresponding
molecule in the tissue sample. Note that the peak
intensity does not exactly represent molecular concen-
trations in the tissue due to the differences in ionization
efficiency, competitive suppression effects or differ-
ences in the degree of fragmentation. However, for the
same molecule in the same tissue type or closely related
compounds in the same tissue, relative peak intensities
should approximately reflect differences in intrinsic
concentrations. This is a standard assumption in imag-
ing studies and it has been discussed and justified in
previous papers [72, 85, 86].
The spatial images of specific lipids and fatty acids in
the 3.8  3.5 mm area of rat spinal cord cross section in
the negative ion mode are shown in Figure 5. For
Figure 6. Selected molecular ion [MNa] im
area of rat spinal cord cross-section in the pos
SM(42:1).comparison, an optical image is provided in Figure 5j
and structural features (white and gray matter) are
indicated. Each selected ion image is plotted on the
same color scale to allow comparison of ion intensity
between images. Ion images show a particular localiza-
tion in either the white matter (light peripheral region
in Figure 5j), which predominantly contains myelinated
axons, or gray matter (dark central region in Figure 5j),
which predominantly contains the cellular bodies. The
image of the ion detected at m/z 750.6, identified as the
deprotonated form of plasm-PE(38:4), shows an ap-
proximately homogeneous distribution in the area of
the spinal cord corresponding to the white matter but
much lower signals in the area corresponding to the
gray matter (Figure 5a). A similar spatial intensity
distribution with even more contrast is observed for the
deprotonated PE(40:4) detected at m/z 794.4 (Figure 5c).
PS, PG, PI, and ST lipids (Figure 5b–f) are also mainly
located in the area corresponding to the white matter
with less abundance in the gray matter. Figure 6 shows
the spatial images of PC(36:1) and SM(42:1) lipids in the
rat spinal cord cross section in the positive ion mode.
Due to the low signal/noise ratio, the quality of the
images is not as good as in the negative ion mode.
Indeed, the lower signal intensity of the detected lipids
(maximum at 80 arbitrary units in positive mode in-
stead of 202 in the negative mode) results in a lower
contrast between the spinal cord tissue and the other
part of the scanned surface. However, positive ion
mode images show the same particular localization in
the white matter and support the interpretations made
from the negative ion data. Signals at m/z 782.5 (Figure
6a) and m/z 837.8 (Figure 6b), which correspond to
sodiated adducts of PC(34:1) and SM(42:1), are more
intense in the white matter. In contrast, the complemen-
tary localization of ion images is observed for the fatty
of specific lipids from analysis of a 3.8 3.5 mm
ion mode. Ion images of (a) PC(34:1) and (b)ages
itive
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detected at m/z 281.4, identified as the deprotonated
form of oleic acid (Figure 5g) is higher in the region of
the spinal cord corresponding to the gray matter, as is
that for arachidonic acid (m/z 303.4; Figure 5h) and
docosahexaenoic acid (m/z 327.4; Figure 5i).
These results agree with the reported studies of rat
brains whereby lipids ions were associated with the
myelinated axons (white matter) [20, 21], while the fatty
acids were present in the region enriched in neuronal
cell bodies (gray matter) [80, 115]. This suggests that the
spatial intensity distribution reflects relative concentra-
tion differences of the lipid and fatty acid compounds in
the spinal cord tissue. The “butterfly” shape of the gray
matter in the spinal cord cross-section is resolved in the
corresponding ion images, indicating that a lateral
resolution of less than 200 m is achieved. The selected
ion images of lipids are directly correlated with ana-
tomic features on the spinal cord corresponding to the
white and the gray matter.
Conclusion
This study has established that DESI imaging MS is a
powerful tool for measuring lipid profiles in rat spinal
cord with a spatial resolution less than 200 m. The
resulting ion images reflect the relative concentrations
of the species detected from the tissue surface. DESI
imaging MS presents advantages in terms of easy
implementation and ambient analysis. MS/MS experi-
ments have also been performed to confirm the identi-
ties of individual compounds. All these chemical and
spatial information may help to a better understanding
of lipid biochemistry within the spinal cord. This work
presents the fundamental information needed to pursue
future studies of spinal cord injury recovery processes.
Indeed, DESI imaging technique will be used in future
studies to determine the spatial distribution and expres-
sion levels of analytes and their changes during the
injury recovery process and to evaluate the effects of
drug treatment.
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